{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alkaloids", "Antivirals", "Avian Influenza Virus (AIV)", "Colchicine", "Seasonal Influenza"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38254071", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "24"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "10"}, "Article": {"Language": ["eng"], "ELocationID": ["49", "10.1186/s12906-023-04303-2"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "22"}], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "22"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle.", "Pagination": {"StartPage": "49", "MedlinePgn": "49"}, "Abstract": {"AbstractText": ["The continuous evolution of drug-resistant influenza viruses highlights the necessity for repurposing naturally-derived and safe phytochemicals with anti-influenza activity as novel broad-spectrum anti-influenza medications.", "In this study, nitrogenous alkaloids were tested for their viral inhibitory activity against influenza A/H1N1 and A/H5N1 viruses. The cytotoxicity of tested alkaloids on MDCK showed a high safety range (CC<sub>50</sub>\u2009>\u2009200 \u00b5g/ml), permitting the screening for their anti-influenza potential.", "Herein, atropine sulphate, pilocarpine hydrochloride and colchicine displayed anti-H5N1 activities with IC<sub>50</sub> values of 2.300, 0.210 and 0.111 \u00b5g/ml, respectively. Validation of the IC<sub>50</sub> values was further depicted by testing the three highly effective alkaloids, based on their potent IC<sub>50</sub> values against seasonal influenza A/H1N1 virus, showing comparable IC<sub>50</sub> values of 0.204, 0.637 and 0.326 \u00b5g/ml, respectively. Further investigation suggests that colchicine could suppress viral infection by primarily interfering with IAV replication and inhibiting viral adsorption, while atropine sulphate and pilocarpine hydrochloride could directly affect the virus in a cell-free virucidal effect. Interestingly, the in silico molecular docking studies suggest the abilities of atropine, pilocarpine, and colchicine to bind correctly inside the active sites of the neuraminidases of both influenza A/H1N1 and A/H5N1 viruses. The three alkaloids exhibited good binding energies as well as excellent binding modes that were similar to the co-crystallized ligands. On the other hand, consistent with in vitro results, only colchicine could bind correctly against the M2-proton channel of influenza A viruses (IAVs). This might explicate the in vitro antiviral activity of colchicine at the replication stage of the virus replication cycle.", "This study highlighted the anti-influenza efficacy of biologically active alkaloids including colchicine. Therefore, these alkaloids should be further characterized in vivo (preclinical and clinical studies) to be developed as anti-IAV agents."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Agricultural Microbiology, Faculty of Agriculture, Cairo University, Giza, 12613, Giza District, Egypt."}], "LastName": "Hegazy", "ForeName": "Akram", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Adham University College, Umm Al-Qura University, 21955, Makkah, Saudi Arabia."}], "LastName": "Soltane", "ForeName": "Raya", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Adham University College, Umm Al-Qura University, 21955, Makkah, Saudi Arabia."}], "LastName": "Alasiri", "ForeName": "Ahlam", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt."}], "LastName": "Mostafa", "ForeName": "Islam", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, 12622, Egypt."}], "LastName": "Mahmoud", "ForeName": "Sara H", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology Lab 176, Water Pollution Research Department, Environment and Climate Change Institute, National Research Centre, Dokki, 12622, Giza, Egypt."}], "LastName": "Allayeh", "ForeName": "Abdou Kamal", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, 12622, Egypt."}], "LastName": "Shama", "ForeName": "Noura M Abo", "Initials": "NMA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Agriculture Research Center (ARC), Veterinary Sera and Vaccines Research Institute (VSVRI), Cairo, 11435, Egypt."}], "LastName": "Khalil", "ForeName": "Ahmed A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Texas Biomedical Research Institute, San Antonio, TX, USA."}], "LastName": "Barre", "ForeName": "Ramya S", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt."}, {"Identifier": [], "Affiliation": "Faculty of Pharmacy, El Saleheya El Gadida University, El Saleheya El Gadida , Sharkia, 44813, Egypt."}], "LastName": "El-Shazly", "ForeName": "Assem Mohamed", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, 12622, Egypt."}], "LastName": "Ali", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Texas Biomedical Research Institute, San Antonio, TX, USA."}], "LastName": "Martinez-Sobrido", "ForeName": "Luis", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, 12622, Egypt. ah.mostafa@nrc.sci.eg."}, {"Identifier": [], "Affiliation": "Texas Biomedical Research Institute, San Antonio, TX, USA. ah.mostafa@nrc.sci.eg."}], "LastName": "Mostafa", "ForeName": "Ahmed", "Initials": "A"}], "GrantList": [{"GrantID": "75N93021C00014", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01 AI145332", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01AI145332", "Acronym": "NH", "Agency": "NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "SML2Y3J35T", "NameOfSubstance": "Colchicine"}, {"RegistryNumber": "01MI4Q9DI3", "NameOfSubstance": "Pilocarpine"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "7C0697DR9I", "NameOfSubstance": "Atropine"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Colchicine"}, {"QualifierName": [], "DescriptorName": "Influenza A virus"}, {"QualifierName": [], "DescriptorName": "Influenza A Virus, H5N1 Subtype"}, {"QualifierName": [], "DescriptorName": "Pilocarpine"}, {"QualifierName": [], "DescriptorName": "Influenza A Virus, H1N1 Subtype"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Influenza, Human"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Seasons"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": [], "DescriptorName": "Atropine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gaitonde DY, Moore FC, Morgan MK. Influenza: diagnosis and treatment. Am Fam Phys. 2019;100(12):751\u20138.", "ArticleIdList": ["31845781"]}, {"Citation": "Lo CY, Tang YS, Shaw PC. Structure and function of Influenza virus ribonucleoprotein. Virus Protein Nucleoprotein Compl. 2018;88:95\u2013128. doi: 10.1007/978-981-10-8456-0_5.", "ArticleIdList": ["10.1007/978-981-10-8456-0_5", "29900494"]}, {"Citation": "Collin EA, Sheng Z, Lang Y, Ma W, Hause BM, Li F. Cocirculation of two distinct genetic and antigenic lineages of proposed Influenza D virus in cattle. J Virol. 2015;89(2):1036\u20131042. doi: 10.1128/JVI.02718-14.", "ArticleIdList": ["10.1128/JVI.02718-14", "PMC4300623", "25355894"]}, {"Citation": "Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005;3(8):591\u2013600. doi: 10.1038/nrmicro1208.", "ArticleIdList": ["10.1038/nrmicro1208", "16064053"]}, {"Citation": "Ding Y, Dou J, Teng Z, Yu J, Wang T, Lu N, Wang H, Zhou C. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase. Arch Virol. 2014;159(12):3269\u20133278. doi: 10.1007/s00705-014-2192-2.", "ArticleIdList": ["10.1007/s00705-014-2192-2", "25078390"]}, {"Citation": "King PT, Londrigan SL. The 1918 influenza and COVID-19 pandemics: the effect of age on outcomes. Respirol (Carlton Vic) 2021;26(9):840. doi: 10.1111/resp.14109.", "ArticleIdList": ["10.1111/resp.14109", "PMC8447138", "34180106"]}, {"Citation": "WHO: COVID-19 weekly epidemiological update, edition 110, 21 September 2022. 2022. Available online at https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---21-september-2022. Accessed 15 Nov 2023."}, {"Citation": "Mostafa A, Abdelwhab EM, Mettenleiter TC, Pleschka S. Zoonotic potential of influenza A viruses: a comprehensive overview. Viruses. 2018;10(9):497. doi: 10.3390/v10090497.", "ArticleIdList": ["10.3390/v10090497", "PMC6165440", "30217093"]}, {"Citation": "Nguyen LT, Stevenson MA, Firestone SM, Sims LD, Chu DH, Van Nguyen L, Nguyen TN, Le KT, Isoda N, Matsuno K. Spatiotemporal and risk analysis of H5 highly pathogenic avian influenza in Vietnam, 2014\u20132017. Prev Vet Med. 2020;178:104678. doi: 10.1016/j.prevetmed.2019.04.007.", "ArticleIdList": ["10.1016/j.prevetmed.2019.04.007", "31113666"]}, {"Citation": "Sealy JE, Fournie G, Trang PH, Dang NH, Sadeyen JR, Thanh TL, van Doorn HR, Bryant JE, Iqbal M. Poultry trading behaviours in Vietnamese live bird markets as risk factors for avian influenza infection in chickens. Transbound Emerg Dis. 2019;66(6):2507\u20132516. doi: 10.1111/tbed.13308.", "ArticleIdList": ["10.1111/tbed.13308", "PMC6899644", "31357255"]}, {"Citation": "Ulyanova V, Shah Mahmud R, Laikov A, Dudkina E, Markelova M, Mostafa A, Pleschka S, Ilinskaya O. Anti-influenza activity of the ribonuclease binase: Cellular targets detected by quantitative proteomics. Int J Mol Sci. 2020;21(21):8294. doi: 10.3390/ijms21218294.", "ArticleIdList": ["10.3390/ijms21218294", "PMC7663932", "33167434"]}, {"Citation": "Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of Influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36\u201344. doi: 10.1016/S1473-3099(11)70295-X.", "ArticleIdList": ["10.1016/S1473-3099(11)70295-X", "22032844"]}, {"Citation": "El-Shesheny R, Bagato O, Kandeil A, Mostafa A, Mahmoud SH, Hassanneen HM, Webby RJ, Ali MA, Kayali G. Re-emergence of amantadine-resistant variants among highly pathogenic avian influenza H5N1 viruses in Egypt. Infect Genet Evol. 2016;46:102\u2013109. doi: 10.1016/j.meegid.2016.10.022.", "ArticleIdList": ["10.1016/j.meegid.2016.10.022", "27876611"]}, {"Citation": "Choi J-G, Kim YS, Kim JH, Chung H-S. Antiviral activity of ethanol extract of Geranii Herba and its components against Influenza viruses via neuraminidase inhibition. Sci Rep. 2019;9(1):1\u201312.", "ArticleIdList": ["PMC6702199", "31431635"]}, {"Citation": "Zhang S, Tian H, Cui J, Xiao J, Wang M, Hu Y. The c-Jun N-terminal kinase (JNK) is involved in H5N1 influenza a virus RNA and protein synthesis. Arch Virol. 2016;161(2):345\u2013351. doi: 10.1007/s00705-015-2668-8.", "ArticleIdList": ["10.1007/s00705-015-2668-8", "26559961"]}, {"Citation": "Cetina-Montejo L, Ayora-Talavera G, Borges-Arg\u00e1ez R. Zeylanone epoxide isolated from diospyros anisandra stem bark inhibits influenza virus in vitro. Arch Virol. 2019;164(6):1543\u20131552. doi: 10.1007/s00705-019-04223-y.", "ArticleIdList": ["10.1007/s00705-019-04223-y", "30905031"]}, {"Citation": "Tran TT, Kim M, Jang Y, Lee HW, Nguyen HT, Nguyen TN, Park HW, Le Dang Q, Kim J-C. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant polygonum chinense. BMC Complement Altern Med. 2017;17(1):1\u201311. doi: 10.1186/s12906-017-1675-6.", "ArticleIdList": ["10.1186/s12906-017-1675-6", "PMC5361735", "28327126"]}, {"Citation": "Mehrbod P, Ebrahimi SN, Fotouhi F, Eskandari F, Eloff JN, McGaw LJ, Fasina FO. Experimental validation and computational modeling of anti-influenza effects of quercetin-3-O-\u03b1-L-rhamnopyranoside from indigenous South African medicinal plant Rapanea melanophloeos. BMC Complement Altern Med. 2019;19(1):1\u201311. doi: 10.1186/s12906-019-2774-3.", "ArticleIdList": ["10.1186/s12906-019-2774-3", "PMC6888925", "31791311"]}, {"Citation": "Watanabe K, Rahmasari R, Matsunaga A, Haruyama T, Kobayashi N. Anti-influenza viral effects of honey in vitro: potent high activity of manuka honey. Arch Med Res. 2014;45(5):359\u2013365. doi: 10.1016/j.arcmed.2014.05.006.", "ArticleIdList": ["10.1016/j.arcmed.2014.05.006", "24880005"]}, {"Citation": "Ben-Shabat S, Yarmolinsky L, Porat D, Dahan A. Antiviral effect of phytochemicals from medicinal plants: applications and drug delivery strategies. Drug Deliv Transl Res. 2020;10(2):354\u2013367. doi: 10.1007/s13346-019-00691-6.", "ArticleIdList": ["10.1007/s13346-019-00691-6", "PMC7097340", "31788762"]}, {"Citation": "Lenz E, M\u00fcller C, Mostafa A, Dzieciolowski J, Kanrai P, Dam S, Cwientzek U, Prenner L-N, Pleschka S. Authorised medicinal product Aspecton\u00ae oral drops containing thyme extract KMTv24497 shows antiviral activity against viruses which cause respiratory infections. J Herb Med. 2018;13:26\u201333. doi: 10.1016/j.hermed.2018.02.003.", "ArticleIdList": ["10.1016/j.hermed.2018.02.003"]}, {"Citation": "Amirkia V, Heinrich M. Alkaloids as drug leads\u2013A predictive structural and biodiversity-based analysis. Phytochem Lett. 2014;10:xlviii\u2013liii. doi: 10.1016/j.phytol.2014.06.015.", "ArticleIdList": ["10.1016/j.phytol.2014.06.015"]}, {"Citation": "Harborne JB. Textbook of Phytochemical Methods. A Guide to Modern Techniques of Plant Analysis. 5th Edition.\u00a0London: Chapman and Hall Ltd;\u00a01998. p. 21\u201372."}, {"Citation": "Lu JJ, Bao JL, Chen XP, Huang M, Wang YT. Alkaloids isolated from natural herbs as the anticancer agents. Evid-based Complement Altern Med. 2012;2012:485042. doi: 10.1155/2012/485042.", "ArticleIdList": ["10.1155/2012/485042", "PMC3440018", "22988474"]}, {"Citation": "Dey P, Kundu A, Kumar A, Gupta M, Lee BM, Bhakta T, Dash S, Kim HS. Recent advances in natural products analysis. edn: Elsevier; 2020. Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids) pp. 505\u2013567."}, {"Citation": "Shi Z, Zou W, Zhu Z, Xiong Z, Li S, Dong P, Zhu Z. Tropane alkaloids (hyoscyamine, scopolamine and atropine) from genus Datura: extractions, contents, syntheses and effects. Ind Crops Prod. 2022;186:115283. doi: 10.1016/j.indcrop.2022.115283.", "ArticleIdList": ["10.1016/j.indcrop.2022.115283"]}, {"Citation": "Roy H, Nandi S. In-silico modeling in drug metabolism and interaction: current strategies of lead discovery. Curr Pharm Design. 2019;25(31):3292\u20133305. doi: 10.2174/1381612825666190903155935.", "ArticleIdList": ["10.2174/1381612825666190903155935", "31481001"]}, {"Citation": "Eissa IH, Ibrahim MK, Metwaly AM, Belal A, Mehany AB, Abdelhady AA, Elhendawy MA, Radwan MM, ElSohly MA, Mahdy HA. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorg Chem. 2021;107:104532. doi: 10.1016/j.bioorg.2020.104532.", "ArticleIdList": ["10.1016/j.bioorg.2020.104532", "33334586"]}, {"Citation": "Zhanzhaxina A, Suleimen Y, Metwaly AM, Eissa IH, Elkaeed EB, Suleimen R, Ishmuratova M, Akatan K, Luyten W. In vitro and in silico cytotoxic and antibacterial activities of a diterpene from cousinia alata schrenk. J Chem. 2021;2021:1. doi: 10.1155/2021/5542455.", "ArticleIdList": ["10.1155/2021/5542455"]}, {"Citation": "Imieje VO, Zaki AA, Metwaly AM, Eissa IH, Elkaeed EB, Ali Z, Khan IA, Falodun A. Antileishmanial derivatives of humulene from Asteriscus hierochunticus with in silico tubulin inhibition potential. Rec Nat Prod. 2021;16:150\u2013171."}, {"Citation": "Mostafa A, Mahmoud SH, Shehata M, M\u00fcller C, Kandeil A, El-Shesheny R, Nooh HZ, Kayali G, Ali MA, Pleschka S. PA from a recent H9N2 (G1-Like) Avian Influenza a virus (AIV) strain carrying lysine 367 confers altered replication efficiency and pathogenicity to contemporaneous H5N1 in mammalian systems. Viruses. 2020;12(9):1046. doi: 10.3390/v12091046.", "ArticleIdList": ["10.3390/v12091046", "PMC7551781", "32962203"]}, {"Citation": "Petersen H, Mostafa A, Tantawy MA, Iqbal AA, Hoffmann D, Tallam A, Selvakumar B, Pessler F, Beer M, Rautenschlein S. NS segment of a 1918 Influenza a virus-descendent enhances replication of H1N1pdm09 and virus-induced cellular immune response in mammalian and avian systems. Front Microbiol. 2018;9:526. doi: 10.3389/fmicb.2018.00526.", "ArticleIdList": ["10.3389/fmicb.2018.00526", "PMC5874506", "29623073"]}, {"Citation": "Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27(3):493\u2013497. doi: 10.1093/oxfordjournals.aje.a118408.", "ArticleIdList": ["10.1093/oxfordjournals.aje.a118408"]}, {"Citation": "Gaush CR, Smith TF. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol. 1968;16(4):588\u2013594. doi: 10.1128/am.16.4.588-594.1968.", "ArticleIdList": ["10.1128/am.16.4.588-594.1968", "PMC547475", "5647517"]}, {"Citation": "Mostafa A, Kandeil A, Kutkat O, Moatasim Y, Rashad AA, Shehata M, Gomaa MR, Mahrous N, Mahmoud SH, AMM Elshaier, Y FDA-approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2. Pharmaceuticals. 2020;13(12):443. doi: 10.3390/ph13120443.", "ArticleIdList": ["10.3390/ph13120443", "PMC7761982", "33291642"]}, {"Citation": "Skariyachan S, Gopal D, Muddebihalkar AG, Uttarkar A, Niranjan V. Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: molecular modelling, docking and dynamic simulation studies. Comput Biol Med. 2021;132:104325. doi: 10.1016/j.compbiomed.2021.104325.", "ArticleIdList": ["10.1016/j.compbiomed.2021.104325", "PMC7954774", "33751995"]}, {"Citation": "Zhou J, Chan L, Zhou S. Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr Med Chem. 2012;19(21):3523\u20133531. doi: 10.2174/092986712801323171.", "ArticleIdList": ["10.2174/092986712801323171", "22680628"]}, {"Citation": "Anwar S, Bhandari U, Panda BP, Dubey K, Khan W, Ahmad S. Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk. J Pharm Biomed Anal. 2018;159:100\u2013112. doi: 10.1016/j.jpba.2018.06.027.", "ArticleIdList": ["10.1016/j.jpba.2018.06.027", "29980011"]}, {"Citation": "\u00d6z\u00e7elik B, Kartal M, Orhan I. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm Biol. 2011;49(4):396\u2013402. doi: 10.3109/13880209.2010.519390.", "ArticleIdList": ["10.3109/13880209.2010.519390", "21391841"]}, {"Citation": "Reid SM, Westbury C, Guzys AT, Reddihough DS. Anticholinergic medications for reducing drooling in children with developmental disability. Dev Med Child Neurol. 2020;62(3):346\u2013353. doi: 10.1111/dmcn.14350.", "ArticleIdList": ["10.1111/dmcn.14350", "31495925"]}, {"Citation": "Vlietinck A, De Bruyne T, Apers S, Pieters L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 1998;64(02):97\u2013109. doi: 10.1055/s-2006-957384.", "ArticleIdList": ["10.1055/s-2006-957384", "9525100"]}, {"Citation": "Wyde PR, Gilbert BE, Ambrose MW. Comparison of the anti-respiratory syncytial virus activity and toxicity of papaverine hydrochloride and pyrazofurin in vitro and in vivo. Antiviral Res. 1989;11(1):15\u201326. doi: 10.1016/0166-3542(89)90017-X.", "ArticleIdList": ["10.1016/0166-3542(89)90017-X", "2653219"]}, {"Citation": "Aggarwal M, Leser GP, Lamb RA. Repurposing papaverine as an antiviral agent against Influenza viruses and paramyxoviruses. J Virol. 2020;94(6):01888\u2013e01819. doi: 10.1128/JVI.01888-19.", "ArticleIdList": ["10.1128/JVI.01888-19", "PMC7158703", "31896588"]}, {"Citation": "Shih T-M, McDonough J. Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication. Arch Toxicol. 2000;74(3):165\u2013172. doi: 10.1007/s002040050670.", "ArticleIdList": ["10.1007/s002040050670", "10877003"]}, {"Citation": "Malakar S, Sreelatha L, Dechtawewat T, Noisakran S, Yenchitsomanus P-t, Chu JJH, Limjindaporn T. Drug repurposing of quinine as antiviral against dengue virus infection. Virus Res. 2018;255:171\u2013178. doi: 10.1016/j.virusres.2018.07.018.", "ArticleIdList": ["10.1016/j.virusres.2018.07.018", "30055216"]}, {"Citation": "Gro\u00dfe M, Ruetalo N, Layer M, Hu D, Businger R, Rheber S, Setz C, Rauch P, Auth J, Fr\u00f6ba M. Quinine inhibits Infection of human cell lines with SARS-CoV-2. Viruses. 2021;13(4):647. doi: 10.3390/v13040647.", "ArticleIdList": ["10.3390/v13040647", "PMC8069458", "33918670"]}, {"Citation": "Seeler A, Graessle O, Ott W. Effect of quinine on Influenza virus Infections in mice. J Infect Dis. 1946;79:156\u2013158. doi: 10.1093/infdis/79.2.156.", "ArticleIdList": ["10.1093/infdis/79.2.156", "20273894"]}, {"Citation": "Yamazaki Z, Tagaya I. Antiviral effects of atropine and caffeine. J Gen Virol. 1980;50(2):429\u2013431. doi: 10.1099/0022-1317-50-2-429.", "ArticleIdList": ["10.1099/0022-1317-50-2-429", "6257827"]}, {"Citation": "Lipton RB, Diener H-C, Robbins MS, Garas SY, Patel K. Caffeine in the management of patients with headache. J Headache Pain. 2017;18(1):1\u201311. doi: 10.1186/s10194-017-0806-2.", "ArticleIdList": ["10.1186/s10194-017-0806-2", "PMC5655397", "29067618"]}, {"Citation": "Tej GNVC, Neogi K, Nayak PK. Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody. Int Immunopharmacol. 2019;77:106002. doi: 10.1016/j.intimp.2019.106002.", "ArticleIdList": ["10.1016/j.intimp.2019.106002", "31711939"]}, {"Citation": "Murayama M, Tsujimoto K, Uozaki M, Katsuyama Y, Yamasaki H, Utsunomiya H, Koyama AH. Effect of caffeine on the multiplication of DNA and RNA viruses. Mol Med Rep. 2008;1(2):251\u2013255.", "ArticleIdList": ["21479405"]}, {"Citation": "Batista MN, Carneiro BM, Braga ACS, Rahal P. Caffeine inhibits hepatitis C virus replication in vitro. Arch Virol. 2015;160(2):399\u2013407. doi: 10.1007/s00705-014-2302-1.", "ArticleIdList": ["10.1007/s00705-014-2302-1", "25491197"]}, {"Citation": "Mohammadi S, Heidarizadeh M, Entesari M, Esmailpour A, Esmailpour M, Moradi R, Sakhaee N, Doustkhah E. In silico investigation on the inhibiting role of nicotine/caffeine by blocking the S protein of SARS-CoV-2 versus ACE2 receptor. Microorganisms. 2020;8(10):1600. doi: 10.3390/microorganisms8101600.", "ArticleIdList": ["10.3390/microorganisms8101600", "PMC7603175", "33080900"]}, {"Citation": "Yim N-H, Kim A, Jung YP, Kim T, Ma CJ, Ma JY. Fermented So-Cheong-Ryong-Tang (FCY) induces apoptosis via the activation of caspases and the regulation of MAPK signaling pathways in cancer cells. BMC Complement Altern Med. 2015;15(1):1\u201311. doi: 10.1186/s12906-015-0821-2.", "ArticleIdList": ["10.1186/s12906-015-0821-2", "PMC4582731", "26403976"]}, {"Citation": "Wei W, Du H, Shao C, Zhou H, Lu Y, Yu L, Wan H, He Y. Screening of antiviral components of Ma Huang Tang and investigation on the ephedra alkaloids efficacy on influenza virus type A. Front Pharmacol. 2019;10:961. doi: 10.3389/fphar.2019.00961.", "ArticleIdList": ["10.3389/fphar.2019.00961", "PMC6747051", "31551774"]}, {"Citation": "Ebada ME. Drug repurposing may generate novel approaches to treating depression. J Pharm Pharmacol. 2017;69(11):1428\u20131436. doi: 10.1111/jphp.12815.", "ArticleIdList": ["10.1111/jphp.12815", "28925030"]}, {"Citation": "Jain N, Verma A, Jain N. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Drug Delivery. 2020;27(1):888\u2013899. doi: 10.1080/10717544.2020.1775726.", "ArticleIdList": ["10.1080/10717544.2020.1775726", "PMC8216479", "32551978"]}, {"Citation": "Nidorf SM, Fiolet AT, Mosterd A, Eikelboom JW, Schut A, Opstal TS, The SH, Xu X-F, Ireland MA, Lenderink T. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838\u20131847. doi: 10.1056/NEJMoa2021372.", "ArticleIdList": ["10.1056/NEJMoa2021372", "32865380"]}, {"Citation": "Schlesinger N, Firestein BL, Brunetti L. Colchicine in COVID-19: an old drug, new use. Curr Pharmacol Rep. 2020;6(4):137\u2013145. doi: 10.1007/s40495-020-00225-6.", "ArticleIdList": ["10.1007/s40495-020-00225-6", "PMC7367785", "32837853"]}, {"Citation": "Yousefi H, Mashouri L, Okpechi SC, Alahari N, Alahari SK. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 Infection: a review describing drug mechanisms of action. Biochem Pharmacol. 2021;183:114296. doi: 10.1016/j.bcp.2020.114296.", "ArticleIdList": ["10.1016/j.bcp.2020.114296", "PMC7581400", "33191206"]}, {"Citation": "McNicholl IR, McNicholl JJ. Neuraminidase inhibitors: zanamivir and oseltamivir. Ann Pharmacother. 2001;35(1):57\u201370. doi: 10.1345/aph.10118.", "ArticleIdList": ["10.1345/aph.10118", "11197587"]}, {"Citation": "Mahmoud A, Mostafa A, Al-Karmalawy AA, Zidan A, Abulkhair HS, Mahmoud SH, Shehata M, Elhefnawi MM, Ali MA. Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies. Heliyon. 2021;7(9):e07962. doi: 10.1016/j.heliyon.2021.e07962.", "ArticleIdList": ["10.1016/j.heliyon.2021.e07962", "PMC8426143", "34518806"]}, {"Citation": "Alesawy MS, Abdallah AE, Taghour MS, Elkaeed EB, Eissa H, Metwaly I. In silico studies of some isoflavonoids as potential candidates against COVID-19 targeting human ACE2 (hACE2) and viral main protease (Mpro) Molecules. 2021;26(9):2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "Nandi S, Kumar M, Saxena AK. Repurposing of drugs and HTS to combat SARS-CoV-2 main protease utilizing structure-based molecular docking. Lett Drug Des Disc. 2022;19(5):413\u201327. doi: 10.2174/1570180818666211007111105.", "ArticleIdList": ["10.2174/1570180818666211007111105"]}, {"Citation": "Hagras M, El Deeb MA, Elzahabi HS, Elkaeed EB, Mehany AB, Eissa IH. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. J Enzyme Inhib Med Chem. 2021;36(1):640\u2013658. doi: 10.1080/14756366.2021.1883598.", "ArticleIdList": ["10.1080/14756366.2021.1883598", "PMC7889231", "33588683"]}, {"Citation": "Eissa IH, Khalifa MM, Elkaeed EB, Hafez EE, Alsfouk AA, Metwaly AM. In silico exploration of potential natural inhibitors against SARS-CoV-2 nsp10. Molecules. 2021;26(20):6151. doi: 10.3390/molecules26206151.", "ArticleIdList": ["10.3390/molecules26206151", "PMC8539059", "34684735"]}, {"Citation": "Eissa IH, Dahab MA, Ibrahim MK, Alsaif NA, Alanazi A, Eissa SI, Mehany AB, Beauchemin AM. Design and discovery of new antiproliferative 1, 2, 4-triazin-3 (2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorg Chem. 2021;112:104965. doi: 10.1016/j.bioorg.2021.104965.", "ArticleIdList": ["10.1016/j.bioorg.2021.104965", "34020238"]}, {"Citation": "Lemon SM, Mahmoud AA. The threat of pandemic influenza: are we ready? Biosec Bioterror. 2005;3(1):70\u201373. doi: 10.1089/bsp.2005.3.70.", "ArticleIdList": ["10.1089/bsp.2005.3.70", "15853457"]}, {"Citation": "Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. The Lancet. 2018;391(10127):1285\u20131300. doi: 10.1016/S0140-6736(17)33293-2.", "ArticleIdList": ["10.1016/S0140-6736(17)33293-2", "PMC5935243", "29248255"]}, {"Citation": "Nuwarda RF, Alharbi AA, Kayser V. An overview of Influenza viruses and vaccines. Vaccines (Basel) 2021;9(9):1032. doi: 10.3390/vaccines9091032.", "ArticleIdList": ["10.3390/vaccines9091032", "PMC8473132", "34579269"]}, {"Citation": "Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet. 2000;355(9206):827\u2013835. doi: 10.1016/S0140-6736(99)11433-8.", "ArticleIdList": ["10.1016/S0140-6736(99)11433-8", "10711940"]}, {"Citation": "Stiver G. The treatment of influenza with antiviral drugs. CMAJ. 2003;168(1):49\u201357.", "ArticleIdList": ["PMC139319", "12515786"]}, {"Citation": "Alasiri A, Soltane R, Hegazy A, Khalil AM, Mahmoud SH, Khalil AA, Martinez-Sobrido L, Mostafa A. Vaccination and antiviral treatment against Avian influenza H5Nx viruses: a harbinger of virus control or evolution. Vaccines. 2023;11:1628. doi: 10.3390/vaccines11111628.", "ArticleIdList": ["10.3390/vaccines11111628", "PMC10675773", "38005960"]}, {"Citation": "Zhang T, Xiao M, Wong C-K, Mok K-PC, Zhao X, Ti H, Shaw P-C. Sheng Jiang San, a traditional multi-herb formulation, exerts anti-influenza effects in vitro and in vivo via neuraminidase inhibition and immune regulation. BMC Complement Altern Med. 2018;18(1):1\u20139. doi: 10.1186/s12906-018-2216-7.", "ArticleIdList": ["10.1186/s12906-018-2216-7", "PMC5941478", "29739459"]}, {"Citation": "Alam M, Nandi S. Current drug design strategies for fighting against swine influenza. Curr Drug Therapy. 2017;12(2):83\u201396. doi: 10.2174/1574885512666170504121055.", "ArticleIdList": ["10.2174/1574885512666170504121055"]}, {"Citation": "WHO. Essential steps for developing or updating a national pandemic Influenza preparedness plan. World Health Organization; 2018. Available at https://www.who.int/publications/i/item/WHO-WHE-IHM-GIP-2018.1. Accessed 15 Nov 2023."}, {"Citation": "Agban Y, Lian J, Prabakar S, Seyfoddin A, Rupenthal ID. Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride. Int J Pharm. 2016;501(1\u20132):96\u2013101. doi: 10.1016/j.ijpharm.2016.01.069.", "ArticleIdList": ["10.1016/j.ijpharm.2016.01.069", "26828672"]}, {"Citation": "Iacobuzio-Donahue CA, Lee EL, Abraham SC, Yardley JH, Wu T-T. Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies. Am J Surg Pathol. 2001;25(8):1067\u20131073. doi: 10.1097/00000478-200108000-00012.", "ArticleIdList": ["10.1097/00000478-200108000-00012", "11474292"]}, {"Citation": "Deysson G. Antimitotic substances. Int Rev Cytol. 1968;24:99\u2013148. doi: 10.1016/S0074-7696(08)61398-4.", "ArticleIdList": ["10.1016/S0074-7696(08)61398-4", "4881355"]}, {"Citation": "McAuley JL, Gilbertson BP, Trifkovic S, Brown LE, McKimm-Breschkin JL. Influenza virus neuraminidase structure and functions. Front Microbiol. 2019;10:39. doi: 10.3389/fmicb.2019.00039.", "ArticleIdList": ["10.3389/fmicb.2019.00039", "PMC6362415", "30761095"]}, {"Citation": "Cross TA, Dong H, Sharma M, Busath DD, Zhou HX. M2 protein from influenza A: from multiple structures to biophysical and functional insights. Curr Opin Virol. 2012;2(2):128\u2013133. doi: 10.1016/j.coviro.2012.01.005.", "ArticleIdList": ["10.1016/j.coviro.2012.01.005", "PMC3322387", "22482709"]}]}], "History": [{"Year": "2022", "Month": "12", "Day": "7"}, {"Year": "2023", "Month": "12", "Day": "10"}, {"Year": "2024", "Month": "1", "Day": "24", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "23", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "23", "Hour": "0", "Minute": "4"}, {"Year": "2024", "Month": "1", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["38254071", "PMC10804494", "10.1186/s12906-023-04303-2", "10.1186/s12906-023-04303-2"]}}]}